Clinical trials · Omaha, NE
Kidney Transplant clinical trials in Omaha
We’re tracking 6 recruiting kidney transplant studies with a site in or near Omaha — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Omaha
- NCT06013865RecruitingPhase 4
Empagliflozin for kidney transplant recipients
This trial tests if empagliflozin, a diabetes medicine that also protects the kidneys, can help people who have received a kidney transplant. It may be an option if you have reduced kidney function or diabetes after transplant.
Omaha, NebraskaAges 19 years+ - NCT05917522RecruitingPhase 2
Biomarker-guided changes to anti-rejection medicines after kidney transplant
This Phase 2 study looks at whether blood test “biomarkers” can guide safely changing anti-rejection medicines after an ABO-compatible kidney transplant. It may help some people reduce certain medicines while keeping the new kidney protected from rejection.
Omaha, NebraskaAges 18–70 - NCT06830798RecruitingPhase 3
Ravulizumab to prevent delayed graft function after kidney transplant
This study tests an investigational medicine (ravulizumab) given through a vein to see if it can prevent delayed graft function—meaning the new kidney takes longer to start working—after a high-risk kidney transplant. It is for adults on dialysis who are getting a kidney from a donor whose heart stopped or who is considered high-risk.
Omaha, NebraskaAges 18 years+ - NCT07444489Enrolling by invitationPhase 3
Long-term safety of felzartamab for kidney transplant rejection
This study checks the long-term safety of felzartamab for people who have had a kidney transplant and are dealing with antibody-mediated rejection or signs of inflammation in the kidney. It's for those who were already in a previous study and took at least one dose of felzartamab.
Omaha, NebraskaAges 18–75 - NCT07219043RecruitingPhase 2
Felzartamab for kidney transplant patients with inflammation
This trial tests a drug called felzartamab to see if it can help people who have a type of kidney inflammation after a transplant, even without donor-specific antibodies. It might offer a new treatment option for those who are not getting better on their own.
Omaha, NebraskaAges 18–74 - NCT06126380Enrolling by invitationPhase 2
Long-term safety of tegoprubart in kidney transplant patients
This is a long-term follow-up study for people who have already completed a study of the drug tegoprubart after a kidney transplant. It checks how safe and effective the drug is over a longer period.
Omaha, NebraskaAges 18–100
Hear when a new Kidney Transplant trial opens near Omaha, NE
We’ll email you when one opens near Omaha, NE — at most once a week, no account needed, unsubscribe anytime.
Kidney Transplant trials in other cities
Where these studies are running near Omaha
Institutions with a site for the recruiting kidney transplant studies listed above.
- University of Nebraska Medical Center · 3 studies
- Omaha VA Nebraska-Western Iowa Health Care System
- Research Site
- University of Nebraska Medical Center (UNMC) - Nebraska Medicine - Nebraska Medical Center
What taking part in a kidney transplant study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting kidney transplant studies in Nebraska.
Common questions
- Are there kidney transplant clinical trials near Omaha?
- Yes. We're currently tracking 6 recruiting kidney transplant studies with a site near Omaha, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a kidney transplant study near Omaha?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Omaha to take part?
- Not necessarily. These studies have a site near Omaha, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a kidney transplant trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New kidney transplant studies open near Omaha regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.